Test Name	CD3G Gene Cone-rod dystrophy type 17 NGS Genetic DNA Test
Test type	Ophthalmologist
Pre-test Information	Clinical History of Patient who is going for CD3G Gene Cone-rod dystrophy type 17 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CD3G Gene Cone-rod dystrophy type 17 NGS Genetic DNA Test gene CD3G
Report Delivery	3 to 4 Weeks
Components
Price	₹ 20000
Method	NGS Technology

Short Description

NGS genetic DNA test detecets for variant and mutation detection in CD3G gene for Cone-rod dystrophy type 17

PreTest Information

Clinical History of Patient who is going for CD3G Gene Cone-rod dystrophy type 17 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CD3G Gene Cone-rod dystrophy type 17 NGS Genetic DNA Test gene CD3G

Detail Description

CD3G Gene Cone-rod dystrophy type 17 NGS Genetic DNA Test

Cone-rod dystrophy type 17 is a rare genetic disorder that affects the retina of the eye and leads to vision loss. It is caused by mutations in the CD3G gene, which provides instructions for making a protein that is important for the immune system and the functioning of the retina. NGS Genetic DNA testing is a highly accurate and efficient way to identify the mutations in the CD3G gene that cause cone-rod dystrophy type 17. This test can help diagnose the condition early, allowing for better management of symptoms and improved outcomes for patients.

Symptoms of Cone-Rod Dystrophy Type 17

The symptoms of cone-rod dystrophy type 17 can vary from person to person, but typically include:

• Decreased visual acuity
• Difficulty seeing colors
• Loss of peripheral vision
• Difficulty seeing in low light conditions

These symptoms usually begin in childhood or early adulthood and can worsen over time.

Diagnosis of Cone-Rod Dystrophy Type 17

Diagnosing cone-rod dystrophy type 17 involves a thorough eye exam, including visual acuity testing, color vision testing, and a dilated eye exam to examine the retina. Genetic testing, such as the NGS Genetic DNA test, can confirm the diagnosis and identify the specific mutations in the CD3G gene that are causing the condition.

Cost of CD3G Gene Cone-Rod Dystrophy Type 17 NGS Genetic DNA Test

The cost of the CD3G Gene Cone-Rod Dystrophy Type 17 NGS Genetic DNA test in India is INR 20,000. This cost includes the test itself, as well as any necessary counseling and support services.

Conclusion

NGS Genetic DNA testing is an important tool for diagnosing cone-rod dystrophy type 17 and identifying the specific mutations in the CD3G gene that are causing the condition. Early diagnosis and management of symptoms can help improve outcomes for patients. If you or a loved one are experiencing symptoms of cone-rod dystrophy type 17, it is important to seek medical attention and consider genetic testing. DNA Labs India offers affordable and reliable genetic testing services, including the CD3G Gene Cone-Rod Dystrophy Type 17 NGS Genetic DNA test.

The CD3G gene encodes a protein called CD3 gamma chain, which is a subunit of the T-cell receptor (TCR) complex found on the surface of T cells. T cells are a type of white blood cell involved in the immune response.

Mutations in the CD3G gene have been linked to Cone-Rod Dystrophy Type 17, which is characterized by the degeneration of cone and rod cells in the retina, leading to vision impairment.

NGS (Next-Generation Sequencing) genetic DNA tests are used to analyze the DNA sequence of genes like CD3G to identify any mutations or variants that may be associated with Cone-Rod Dystrophy Type 17.

If you or someone you know is considering genetic testing for Cone-Rod Dystrophy related to the CD3G gene, I recommend consulting with an ophthalmologist (eye specialist), a medical geneticist, or a genetic counselor. They can provide accurate and current information about the condition, the implications of genetic testing, and any available treatment options. Medical knowledge can evolve, so it's important to rely on expert guidance for the latest information.